Valneva reports positive results for its COVID-19 vaccine candidate
Valneva reported positive Phase III results on Monday for its inactivated, adjuvanted COVID-19 vaccine candidate VLA2001, a boost for the French biotech company after Britain cancelled a big deal to buy its shot. Valneva said its latest trial which was conducted on 4,012 participants aged 18 years and older across 26 trial sites in Britain and showed the vaccine prompted a stronger immune response and fewer side-effects than AstraZeneca's shot.
Valneva reported positive Phase III results on Monday for its inactivated, adjuvanted COVID-19 vaccine candidate VLA2001, a boost for the French biotech company after Britain cancelled a big deal to buy its shot.
Valneva said its latest trial which was conducted on 4,012 participants aged 18 years and older across 26 trial sites in Britain and showed the vaccine prompted a stronger immune response and fewer side-effects than AstraZeneca's shot. Valneva is among a handful of vaccine developers testing their vaccines against one that's already been approved by a regulator rather than giving volunteers a dummy placebo as shots become more available.
"These results confirm the advantages often associated with inactivated whole virus vaccines," said Valneva Chief Executive Thomas Lingelbach, adding that the company believed it would make an important contribution to the fight against COVID-19. Valneva said it was preparing for trials in children aged 5-12 years and for a Valneva-sponsored trial to evaluate VLA2001's performance for people in need of a COVID-19 vaccine booster shot.
The company's shares plunged last month after Britain cancelled a contract for about 100 million doses of the vaccine Valneva was developing, partly over concerns about when it would win approval for use. Valneva has been expanding the trials of its VLA2001 COVID-19 vaccine candidate, and remains in talks with the European Commission over a potential contract.
(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)
- READ MORE ON:
- VLA2001
- European Commission
- AstraZeneca
- French
- Valneva
- Britain
ALSO READ
European Commission expected to propose new sanctions on Russian LNG, sources say
European Commission expected to propose new sanctions on Russian LNG, sources say
FTSE 100 continues record run boosted by Anglo American, AstraZeneca
China's Xi to meet French president, European Commission chief next week
Clot in blood vessels occurs in rare cases with certain vaccines: Medical Expert amid reports over AstraZeneca